Acute Intermittent Porphyria Global Market Report 2024

Global Acute Intermittent Porphyria Market Report 2024

Acute Intermittent Porphyria Global Market Report 2024 – By Diagnosis (Urine Test, Blood Test, Serum Test, DNA Test, Other Diagnosis), By Treatment (Prophylactic Hematin Infusions, Gonadotropin-Releasing Hormone Analogues, Other Treatments), By End-Users (Hospitals And Clinics, Ambulatory Surgical Centers, Research Centers) – Market Size, Trends, And Global Forecast 2024-2033

Name: Acute Intermittent Porphyria Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Acute Intermittent Porphyria Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Global Acute Intermittent Porphyria Market Infographic

Proud Members Of

Acute Intermittent Porphyria Market Definition

Acute intermittent porphyria (AIP) is a rare genetic disorder that affects the production of heme, a vital component of hemoglobin in the blood. AIP is characterized by intermittent attacks of severe abdominal pain, gastrointestinal disturbances, and neurological symptoms, including muscle weakness, seizures, and mental changes such as anxiety, confusion, or hallucinations.

The main acute intermittent porphyria diagnoses include urine tests, blood tests, serum tests, DNA tests, and others. The urine test method involves analyzing a sample of urine to detect elevated levels of porphyrins or their precursors, which are indicators of acute intermittent porphyria (AIP). It offers various types of treatments, such as prophylactic hematin infusions, gonadotropin-releasing hormone analogues, and others, and it is used by hospitals and clinics, ambulatory surgical centers, and research centers.

Acute Intermittent Porphyria Market Segmentation

The acute intermittent porphyria market covered in this report is segmented –

1) By Diagnosis: Urine Test, Blood Test, Serum Test, DNA Test, Other Diagnosis

2) By Treatment: Prophylactic Hematin Infusions, Gonadotropin-Releasing Hormone Analogues, Other Treatments

3) By End-Users: Hospitals And Clinics, Ambulatory Surgical Centers, Research Centers

Global Acute Intermittent Porphyria Market Size 2023 to 2028: Graph

Acute Intermittent Porphyria Market Size 2024 And Growth Rate

The acute intermittent porphyria market size has grown strongly in recent years. It will grow from $4.11 billion in 2023 to $4.37 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising healthcare expenditure, growth in biopharmaceuticals market, rising prevalence of genetic disorders, expansion of telemedicine services, and growing focus on early detection.

Acute Intermittent Porphyria Market Growth Forecast

The acute intermittent porphyria market size is expected to see strong growth in the next few years. It will grow to $5.61 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing incidence of acute intermittent porphyria, growing awareness of rare diseases, supportive government policies, growing patient advocacy, and expansion of genetic testing services. Major trends in the forecast period include advancements in diagnostic techniques, development of novel therapeutic options, investment in research and development, collaborations between pharma companies, and technological innovations in treatment.

Book your 30 minutes free consultation with our research experts

Acute Intermittent Porphyria Market Driver: Impact Of Rising Metabolic Disorders On The Growth Of The Acute Intermittent Porphyria Market

The prevalence of metabolic disorders is expected to propel the growth of the acute intermittent porphyria market going forward. Metabolic disorders are a group of conditions that occur due to abnormal chemical reactions in the body that disrupt the normal process of metabolism. The prevalence of metabolic disorders is due to genetic factors, lifestyle factors, environmental influences, and increased awareness and diagnosis. The rise in metabolic disorders is encouraging the pharmaceutical industry to invest in treatments for rare and genetic conditions such as acute intermittent porphyria. For instance, in December 2023, according to Cleveland Clinic, a US-based nonprofit academic medical center, inherited metabolic disorders collectively impact approximately 1 in 1,000 to 2,500 births worldwide. Therefore, the prevalence of metabolic disorders is driving the growth of the acute intermittent porphyria market.

Global Acute Intermittent Porphyria Market Major Players

Major companies operating in the acute intermittent porphyria market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Vertex Pharmaceuticals Inc., Eisai Co. Ltd., Octapharma AG, BioMarin Pharmaceutical Inc., Swedish Orphan Biovitrum AB, Alnylam Pharmaceuticals Inc., Mylan N.V., Clinuvel Pharmaceuticals Ltd., Recordati Rare Diseases Inc.

Global Acute Intermittent Porphyria Market Trend: Innovations In Acute Intermittent Porphyria Management

Major companies operating in the acute intermittent porphyria market are focused on developing innovative products, such as acute intermittent porphyria management tablets, to serve customers with advanced features better. Acute intermittent porphyria management tablets refer to oral medications used to manage or prevent the symptoms and acute attacks associated with AIP. For instance, in October 2023, Alembic Pharmaceuticals Ltd., an India-based pharmaceutical company, announced the US Food & Drug Administration (USFDA) approval for its Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg. Chlorpromazine hydrochloride tablets USP, available in doses of 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg, are used to manage the symptoms of psychotic disorders and treat schizophrenia. They also help control nausea and vomiting, alleviate restlessness and apprehension before surgery, and serve as an adjunct in treating tetanus. Additionally, these tablets are utilized in the management of acute intermittent porphyria, control manic symptoms of manic-depressive illness, and provide relief from intractable hiccups.

Acute Intermittent Porphyria Market Merger And Acquisition: American Porphyria Foundation Partners With Recordati Rare Diseases To Advance AIP Awareness And Support

In April 2024, the American Porphyria Foundation (APF), a US-based non-profit organization, partnered with Recordati Rare Diseases. Through this partnership, the American Porphyria Foundation (APF) aims to raise awareness of porphyria and enhance public understanding and support for AIP. Recordati Rare Diseases is an Italy-based pharmaceutical company treating acute intermittent porphyria (AIP).

Regional Insights For The Global Acute Intermittent Porphyria Market

North America was the largest region in the acute intermittent porphyria market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute intermittent porphyria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute intermittent porphyria market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute intermittent porphyria market consists of revenues earned by entities by providing services such as genetic testing, clinical consultation, treatment planning and medication management. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute intermittent porphyria market also includes sales of symptom management products, medical devices, nutritional supplements and emergency kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The acute intermittent porphyria market research report is one of a series of new reports from The Business Research Company that provides acute intermittent porphyria market statistics, including acute intermittent porphyria industry global market size, regional shares, competitors with a acute intermittent porphyria market share, detailed acute intermittent porphyria market segments, market trends and opportunities, and any further data you may need to thrive in the acute intermittent porphyria industry. This acute intermittent porphyria market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Acute Intermittent Porphyria Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2024	$ 4.37 Billion
Revenue Forecast In 2033	$ 5.61 Billion
Growth Rate	CAGR of 6.40% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Diagnosis: Urine Test, Blood Test, Serum Test, DNA Test, Other Diagnosis 2) By Treatment: Prophylactic Hematin Infusions, Gonadotropin-Releasing Hormone Analogues, Other Treatments 3) By End-Users: Hospitals And Clinics, Ambulatory Surgical Centers, Research Centers
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Vertex Pharmaceuticals Inc., Eisai Co. Ltd., Octapharma AG, BioMarin Pharmaceutical Inc., Swedish Orphan Biovitrum AB, Alnylam Pharmaceuticals Inc., Mylan N.V., Clinuvel Pharmaceuticals Ltd., Recordati Rare Diseases Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Acute Intermittent Porphyria Market Characteristics

3. Acute Intermittent Porphyria Market Trends And Strategies

4. Acute Intermittent Porphyria Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Acute Intermittent Porphyria Market Size and Growth

5.1. Global Acute Intermittent Porphyria Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Acute Intermittent Porphyria Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Acute Intermittent Porphyria Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acute Intermittent Porphyria Market Segmentation

6.1. Global Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Urine Test

Blood Test

Serum Test

DNA Test

Other Diagnosis

6.2. Global Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Prophylactic Hematin Infusions

Gonadotropin-Releasing Hormone Analogues

Other Treatments

6.3. Global Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals And Clinics

Ambulatory Surgical Centers

Research Centers

7. Acute Intermittent Porphyria Market Regional And Country Analysis

7.1. Global Acute Intermittent Porphyria Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Acute Intermittent Porphyria Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acute Intermittent Porphyria Market

8.1. Asia-Pacific Acute Intermittent Porphyria Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acute Intermittent Porphyria Market

9.1. China Acute Intermittent Porphyria Market Overview

9.2. China Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acute Intermittent Porphyria Market

10.1. India Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acute Intermittent Porphyria Market

11.1. Japan Acute Intermittent Porphyria Market Overview

11.2. Japan Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acute Intermittent Porphyria Market

12.1. Australia Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acute Intermittent Porphyria Market

13.1. Indonesia Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acute Intermittent Porphyria Market

14.1. South Korea Acute Intermittent Porphyria Market Overview

14.2. South Korea Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acute Intermittent Porphyria Market

15.1. Western Europe Acute Intermittent Porphyria Market Overview

15.2. Western Europe Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acute Intermittent Porphyria Market

16.1. UK Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acute Intermittent Porphyria Market

17.1. Germany Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acute Intermittent Porphyria Market

18.1. France Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acute Intermittent Porphyria Market

19.1. Italy Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acute Intermittent Porphyria Market

20.1. Spain Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acute Intermittent Porphyria Market

21.1. Eastern Europe Acute Intermittent Porphyria Market Overview

21.2. Eastern Europe Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acute Intermittent Porphyria Market

22.1. Russia Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acute Intermittent Porphyria Market

23.1. North America Acute Intermittent Porphyria Market Overview

23.2. North America Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acute Intermittent Porphyria Market

24.1. USA Acute Intermittent Porphyria Market Overview

24.2. USA Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acute Intermittent Porphyria Market

25.1. Canada Acute Intermittent Porphyria Market Overview

25.2. Canada Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acute Intermittent Porphyria Market

26.1. South America Acute Intermittent Porphyria Market Overview

26.2. South America Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acute Intermittent Porphyria Market

27.1. Brazil Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acute Intermittent Porphyria Market

28.1. Middle East Acute Intermittent Porphyria Market Overview

28.2. Middle East Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acute Intermittent Porphyria Market

29.1. Africa Acute Intermittent Porphyria Market Overview

29.2. Africa Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acute Intermittent Porphyria Market Competitive Landscape And Company Profiles

30.1. Acute Intermittent Porphyria Market Competitive Landscape

30.2. Acute Intermittent Porphyria Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Johnson & Johnson

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Roche Holding AG

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Merck & Co. Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. AbbVie Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Acute Intermittent Porphyria Market Other Major And Innovative Companies

31.1. Sanofi SA

31.2. AstraZeneca Plc

31.3. Novartis AG

31.4. GlaxoSmithKline Plc

31.5. Takeda Pharmaceutical Company Limited

31.6. Eli Lilly and Company

31.7. Gilead Sciences Inc.

31.8. Amgen Inc.

31.9. Novo Nordisk A/S

31.10. Regeneron Pharmaceuticals Inc.

31.11. Daiichi Sankyo Company Limited

31.12. Vertex Pharmaceuticals Inc.

31.13. Eisai Co. Ltd.

31.14. Octapharma AG

31.15. BioMarin Pharmaceutical Inc.

32. Global Acute Intermittent Porphyria Market Competitive Benchmarking

33. Global Acute Intermittent Porphyria Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acute Intermittent Porphyria Market

35. Acute Intermittent Porphyria Market Future Outlook and Potential Analysis

35.1 Acute Intermittent Porphyria Market In 2028 - Countries Offering Most New Opportunities

35.2 Acute Intermittent Porphyria Market In 2028 - Segments Offering Most New Opportunities

35.3 Acute Intermittent Porphyria Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Figure 1:

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Figure 3: Global Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 4: Global Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 5: Global Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 6: Global Acute Intermittent Porphyria Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 7: Global Acute Intermittent Porphyria Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 8: Asia-Pacific, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 9: Asia-Pacific, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 10: Asia-Pacific, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 11: China, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 12: China, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 13: China, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 14: India, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 15: India, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 16: India, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 17: Japan, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 18: Japan, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 19: Japan, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 20: Australia, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 21: Australia, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 22: Australia, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 23: Indonesia, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 24: Indonesia, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 25: Indonesia, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 26: South Korea, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 27: South Korea, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 28: South Korea, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 29: Western Europe, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 30: Western Europe, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 31: Western Europe, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 32: UK, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 33: UK, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 34: UK, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 35: Germany, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 36: Germany, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 37: Germany, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 38: France, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 39: France, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 40: France, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 41: Italy, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 42: Italy, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 43: Italy, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 44: Spain, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 45: Spain, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 46: Spain, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 47: Eastern Europe, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 48: Eastern Europe, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 49: Eastern Europe, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 50: Russia, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 51: Russia, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 52: Russia, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 53: North America, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 54: North America, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 55: North America, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 56: USA, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 57: USA, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 58: USA, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 59: Canada, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 60: Canada, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 61: Canada, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 62: South America, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 63: South America, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 64: South America, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 65: Brazil, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 66: Brazil, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 67: Brazil, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 68: Middle East, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 69: Middle East, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 70: Middle East, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 71: Africa, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 72: Africa, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 73: Africa, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 74: Pfizer Inc. Financial Performance
Figure 75: Johnson & Johnson Financial Performance
Figure 76: Roche Holding AG Financial Performance
Figure 77: Merck & Co. Inc. Financial Performance
Figure 78: AbbVie Inc. Financial Performance

List Of Figures

Table 1:

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 6: Global Acute Intermittent Porphyria Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 7: Global Acute Intermittent Porphyria Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 8: Asia-Pacific, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 9: Asia-Pacific, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 10: Asia-Pacific, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 11: China, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 12: China, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 13: China, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 14: India, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 15: India, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 16: India, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 17: Japan, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 18: Japan, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 19: Japan, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 20: Australia, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 21: Australia, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 22: Australia, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 23: Indonesia, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 24: Indonesia, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 25: Indonesia, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 26: South Korea, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 27: South Korea, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 28: South Korea, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 29: Western Europe, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 30: Western Europe, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 31: Western Europe, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 32: UK, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 33: UK, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 34: UK, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 35: Germany, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 36: Germany, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 37: Germany, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 38: France, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 39: France, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 40: France, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 41: Italy, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 42: Italy, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 43: Italy, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 44: Spain, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 45: Spain, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 46: Spain, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 47: Eastern Europe, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 48: Eastern Europe, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 49: Eastern Europe, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 50: Russia, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 51: Russia, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 52: Russia, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 53: North America, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 54: North America, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 55: North America, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 56: USA, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 57: USA, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 58: USA, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 59: Canada, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 60: Canada, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 61: Canada, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 62: South America, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 63: South America, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 64: South America, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 65: Brazil, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 66: Brazil, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 67: Brazil, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 68: Middle East, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 69: Middle East, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 70: Middle East, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 71: Africa, Acute Intermittent Porphyria Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 72: Africa, Acute Intermittent Porphyria Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 73: Africa, Acute Intermittent Porphyria Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 74: Pfizer Inc. Financial Performance
Table 75: Johnson & Johnson Financial Performance
Table 76: Roche Holding AG Financial Performance
Table 77: Merck & Co. Inc. Financial Performance
Table 78: AbbVie Inc. Financial Performance

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Acute Myeloid Leukemia Global Market Report 2024 – By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By End-User (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acute Ischemic Stroke Drugs Global Market Report 2024 – By Type (Tablet, Capsule, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hospitals, Diagnostic Centers, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Post-Acute Care Global Market Report 2024 – By Service (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long Term Care Hospitals, Hospice Care, Home Healthcare Agencies, Other Services), By Conditions (Amputations, Wound Management, Brain Injury, Spinal Cord Injury, Neurological Disorders, Other Conditions), By Age (Elderly, Adult, Others), By Delivery Model (Hospital-Based, Freestanding, Home-Based), By Application (Chronic Care, Rehabilitation, Post-Acute Care) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acute Pancreatitis Global Market Report 2024 – By Cause (Gallstones, Alcohol, Other Causes), By Treatment (Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Other treatments), By Diagnosis (Imaging tests, Laboratory Tests), By End Users (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acute Ischemic Stroke Diagnosis Global Market Report 2024 – By Diagnostic Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography (ECG), Echocardiography, Other Diagnostics), By Surgery Type (Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy), By Application (Tissue Plasminogen Activator (TPA), Anticoagulant, Antiplatelet, Antihypertensive) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acute Spinal Cord Injury Global Market Report 2024 – By Type (Complete Spinal Cord Injury, Incomplete Spinal Cord Injury), By Diagnosis Type (Laboratory Tests, Imaging Tests), By Application (Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acute Coronary Syndrome Global Market Report 2024 – By Type (Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, Unstable Angina), By Treatment (Medications, Statins, Beta blockers, ACE inhibitors, Anticoagulants, Other Treatment), By Diagnosis (Stress Test, Blood Tests, Imaging, Other Diagnosis), By Route Of Administration (Oral, Parenteral), By End-User (Hospitals, Specialty clinics, Other End User) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024 – By Type (Diagnosis, Treatment), By Cause (COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes), By Severity (Mild, Moderate, Severe), By End User (Hospitals, Clinics, Ambulatory Service Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the acute intermittent porphyria market?

How will the acute intermittent porphyria market drivers and restraints affect the acute intermittent porphyria market dynamics? What forces will shape the acute intermittent porphyria industry going forward?

The acute intermittent porphyria market major growth driver - Impact Of Rising Metabolic Disorders On The Growth Of The Acute Intermittent Porphyria Market. For further insights on the acute intermittent porphyria market, request a sample here

What is the forecast market size or the forecast market value of the acute intermittent porphyria market?

The acute intermittent porphyria market size has grown strongly in recent years. It will grow from $4.11 billion in 2023 to $4.37 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising healthcare expenditure, growth in biopharmaceuticals market, rising prevalence of genetic disorders, expansion of telemedicine services, and growing focus on early detection. The acute intermittent porphyria market size is expected to see strong growth in the next few years. It will grow to $5.61 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing incidence of acute intermittent porphyria, growing awareness of rare diseases, supportive government policies, growing patient advocacy, and expansion of genetic testing services. Major trends in the forecast period include advancements in diagnostic techniques, development of novel therapeutic options, investment in research and development, collaborations between pharma companies, and technological innovations in treatment. For further insights on the acute intermittent porphyria market, request a sample here

How is the acute intermittent porphyria market segmented?

The acute intermittent porphyria market is segmented
1) By Diagnosis: Urine Test, Blood Test, Serum Test, DNA Test, Other Diagnosis
2) By Treatment: Prophylactic Hematin Infusions, Gonadotropin-Releasing Hormone Analogues, Other Treatments
3) By End-Users: Hospitals And Clinics, Ambulatory Surgical Centers, Research Centers For further insights on the acute intermittent porphyria market, request a sample here

Which region has the largest share of the acute intermittent porphyria market? What are the other regions covered in the report?

North America was the largest region in the acute intermittent porphyria market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute intermittent porphyria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the acute intermittent porphyria market, request a sample here.

Who are the major players in the acute intermittent porphyria market?

What are the key trends in the acute intermittent porphyria market?

Major trend in the acute intermittent porphyria market - Innovations In Acute Intermittent Porphyria Management. For further insights on the acute intermittent porphyria market, request a sample here.

What are the major opportunities in the acute intermittent porphyria market? What are the strategies for the acute intermittent porphyria market?

For detailed insights on the major opportunities and strategies in the acute intermittent porphyria market, request a sample here.

How does the acute intermittent porphyria market relate to the overall economy and other similar markets?

For detailed insights on acute intermittent porphyria market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the acute intermittent porphyria industry?

For detailed insights on the mergers and acquisitions in the acute intermittent porphyria industry, request a sample here.

What are the key dynamics influencing the acute intermittent porphyria market growth? SWOT analysis of the acute intermittent porphyria market.

For detailed insights on the key dynamics influencing the acute intermittent porphyria market growth and SWOT analysis of the acute intermittent porphyria industry, request a sample here.